Strategic objectives

Consolidate the research group, once the younger members complete their doctorate thesis in 2018-2019 and choose more stable positions, situate the group as experts in pharmacoepidemiological research in collaboration with Spanish and/or international groups.

Consolidate PIELenRed in the Community of Madrid as an interdisciplinary research platform and extend the collaboration to other hospitals in the national territory, maintaining our association with the international consortium, RegiSCAR.

Expand access to other sources of information in addition to BIFAP.

Research lines

• Atherothrombotic events and the use of drugs.
• Severe cutaneous drug reactions (type IV hypersensitivity reactions). Clinical epidemiological studies and the search for susceptibility markers
• Pharmacoepidemiological evaluation of chemoprotectors in colorectal cancer.